Skip to content
Abierto
Menu

Award notice

Safety Evaluation and Toxicology Studies and Related Services for Drug Development

75N95024D00023

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Charles River Laboratories, Inc.

$48,622,546.00 on the award notice, August 12, 2024, contract 75N95024D00023

Description

As published on SAM.gov.

This synopsis of contract award is published pursuant to FAR Subpart 5.3.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Charles River Laboratories, Inc.
UEI
NAPSK1UAMAE5
CAGE
5A148
Vendor location
Wilmington, MA
Contract
75N95024D00023
Obligated
$0.00, potential $48,622,546
Actions
1 between August 12, 2024 and August 12, 2024
Competition
Full and Open Competition, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Safety Evaluation and Toxicology Studies and Related Services for Drug Development
Match
award number 75N95024D00023 equals the contract number; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 13, 2024

    Award notice, originally solicitation

    Awarded to CHARLES RIVER LABORATORIES, Inc. Wilmington for $48,622,546. SAM.gov, notice bc6195f2e1ab4f88a93400e5d1394d00

Points of contact

Also open from this buyer